Zhi‐Xiu Lin
Impact in
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds
- Berberine and alkaloids research
- Biological Psychiatry top 5%
Papers in
-
- Tryptophan and brain disorders 8
- Pharmacology 18
Zhi‐Xiu Lin
147 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 133
- Pharmacology 599
- Biological Psychiatry 141
- Complementary and alternative medicine 436
- Pharmacology 591
- Neurology 286
Countries citing papers authored by Zhi‐Xiu Lin
This map shows the geographic impact of Zhi‐Xiu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi‐Xiu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi‐Xiu Lin more than expected).
Fields of papers citing papers by Zhi‐Xiu Lin
This network shows the impact of papers produced by Zhi‐Xiu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi‐Xiu Lin. The network helps show where Zhi‐Xiu Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhi‐Xiu Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 18 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 50 | |
| 6 | 2023 | 28 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 16 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 14 | |
| 13 | 2020 | 35 | |
| 14 | 2020 | 143 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 24 | |
| 17 | 2019 | 67 | |
| 18 | 2018 | 27 | |
| 19 | 2011 | 15 | |
| 20 | 2009 | 15 |
About Zhi‐Xiu Lin
Zhi‐Xiu Lin is a scholar working on Biological Psychiatry, Pharmacology, Complementary and alternative medicine, Developmental Neuroscience and Immunology and Allergy, having authored 150 papers that have together received 4.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (21 papers), Genomics, phytochemicals, and oxidative stress (11 papers), Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Dermatology and Skin Diseases (11 papers), Nerve injury and regeneration (10 papers), Allergic Rhinitis and Sensitization (9 papers), Tryptophan and brain disorders (8 papers) and Phytochemical compounds biological activities (8 papers). The work is most often cited by research in Pharmacology (599 citations), Biological Psychiatry (141 citations), Complementary and alternative medicine (436 citations), Pharmacology (591 citations) and Neurology (286 citations). Zhi‐Xiu Lin has collaborated with scholars based in Hong Kong, China and Macao. Frequent co-authors include Yan‐Fang Xian, Ziren Su, Siu‐Po Ip, Wen Yang, Qingqing Xu, Qiuju Yuan, Xiao‐Ping Lai, Zhengquan Lai, Qing‐Qiu Mao and Jiannan Chen. Their work appears in journals such as Chinese Medicine, Journal of Ethnopharmacology, Frontiers in Pharmacology, Phytomedicine and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.